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Investigators  are divided into  two well defined groups with refer- 
ence to the interpretation  of the relation of certain streptococci culti- 
vated  from  poliomyelitic nervous tissues  to  epidemic  poliomyelitis. 
One  group  1 affirms  that  the  streptococci  bear  a  causal  relation  to 
poliomyelitis and  are even related biologically to the globoid bodies 
of Flexner and Noguchi~  ~ while another group  a denies that they pos- 
sess  any  essential  etiologic  importance  and  views  them  merely  as 
secondary invaders. 4 
The  question  at issue is an important  one in every way, because 
upon its true answer will depend the prophylactic measures adopted 
to prevent epidemics of poliomyelitis and  the direction which effort 
will take in perfecting an efficient agent for specific therapy. 
Until recently the effort made to  treat  cases of poliomyelitis spe~ 
cifically has been with the blood serum of convalescent and recovered 
cases of the disease.  This procedure is based upon several kinds of 
conclusive  experimental  data.  However,  too  few  observations  are 
available  to  decide  whether  the  method  gives  unmistakable  thera- 
1 Mathers,  G., J. Am. Med. Assn.,  1916, Ixvii, 1019; J. Infect.  Dis.,  1917, xx, 
113.  Rosenow, E. C., Towne, E. B., and Wheeler, G. W., J. Am. Med. Assn., 
1916, Ixvii, 1202; Science, 1916, xliv, 614; J. Am. Med.  Assn.,  1917, lxviii, 280. 
Nuzum, J. W., and Herzog, M., J. Am. Med. Assn., 1916, lxvli, 1205.  Nuzum, 
J. W., ib/d., 1916, Ixvii, 1437; 1917, lxviii, 24. 
2 Flexner, S., and Noguchi, H., J. Exp. Med., 1913, xviii, 461. 
3  Bull, C. G., J. Exp. Med., 1917, xxv, 557.  Kolmer, J. A., Brown, C. P., and 
Freese, A. M., J. Exp. Med.,  1917, xxv, 789. 
4 Smillie, W. G., J. Exp. Med., I918, xxvli (in press). 
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peutic results  in  human  cases of poliomyelitis,  although  the  indica- 
tions are favorable.  5 
The  employment  of  the  serum  derived  from  recovered  cases  of 
poliomyelitis  followed not  only  on  account  of  the  detection  of  its 
neutralizing  property  in vitro  for  the  poliomyelitic  virus,  but  also 
because  of  the  failure  to  induce  antibody  formation  in  a  variety 
of domestic animals,  including  the  horse,  by  the  injection  of  the 
nervous  tissues  of  monkey  or man  carrying  the  virus2  Incident- 
ally, it may be stated  that  only imperfect success in developing anti- 
bodies in  rabbits and monkeys has attended the repeated injection of 
cultures of the globoid bodiesJ 
A  far greater measure of success has been claimed for the strepto- 
cocci in  producing  antibodies  for  the  virus of poliomyelitis.  Rose- 
now s and Nuzum and Willy  ° assert that animals immunized with the 
streptococci  cultivated  from  poliomyelific cases exhibit  various  an- 
tagonisms  to  the  virus.  Monkeys inoculated  with  streptococci are 
said to be protected from subsequent infection with the poliomyelific 
virus; the blood of the  protected  monkeys  is  stated to be neutraliz- 
ing/n vitro for the virus; and finally, horses immunized with the virus 
are  said  to  yield  a  serum  which  possesses neutralizing,  protective, 
and therapeutic properties,  even when applied to man. 
It is this last statement which calls for painstaking  control.  It is 
obvious that to obtain a decision from the treatment of human cases 
of poliomyelitis would require  a  large  and  varied  series of observa- 
tions extending over a  long period of time and embracing epidemics 
of considerable  magnitude  and  various  degrees  of  severity.  More- 
over, the observations would have to be carefully controlled by com- 
parison  with  an  equal  number  of  cases, occurring  simultaneously, 
untreated  with  the  antiserum,  under  approximately identical  condi- 
tions  and  equally accurately  studied.  To  secure  these  data  might 
requir e  several years,  as has  been  the  case notably with  the  serum 
treatment of diphtheria and epidemic meningitis.  The question arises, 
s Amoss, H. L., and Chesney, A. M., ].  Exp. Med.,  1917, xxv, 581. 
s Flexner, S., J. Am. Med. Assn.,  1910, iv, 1105. 
Amoss, H. L., J. Exp. Med.,  1917, xxv, 545. 
8 Rosenow, E. C., J. Am. Med. Assn.,  1917, lxix, 261, 1074. 
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therefore,  whether a  method is not available by means of which  a 
probable  decision  may  be  reached  more  expeditiously  and  with 
greater certainty.  It is because of our belief that a  decisive experi- 
mental method is at hand that the series of experiments to be reported 
were performed. 
EXPEI~I~ENTAL. 
The injection intracerebral!y into monkeys of minute quantifies of 
an active virus of poliomyelitis is followed by paralysis and, as a rule, 
by death of the animal.  The injection of far greater quantities of  the 
same virus into the blood stream produces no symptoms.  If, how- 
ever, as Flexner and Amoss  ~°, ~ have shown, the meninges and choroid 
plexus  are chemically  inflamed by  a  simultaneous or previ6us  in- 
jection of sterile horse serum, monkey serum, or even isotonic saline 
solution, the virus is enabled to pass from the blood into the nervous 
tissues and thus to induce the characteristic changes which lead to 
paralysis and even to death.  The same authors found only one sub- 
stance which, when injected intraspinally, prevented the localization 
of the virus in  the nervous organs after intravenous injection, and 
that  is  the  serum  derived  from  monkeys which  have  survived  a 
poliomyelitic infection.  Moreover, this serum is capable of setting 
aside the effects of the chemical inflammation  ~  incited by horse serum 
or other foreign fluids injected intraspinally.  In other words, when 
the immune convalescent serum is introduced into  the meninges in 
animals previous!y injected intraspinally with horse serum or other 
fluids mentioned, followed by an intravenous injection of the virus, 
no paralysis or other evidence of infection results.  This experiment 
gives such decisive and unequivocal results that it seems particularly 
adapted to determine the therapeutic value of a serum or other product 
reputed to be effective in the treatment of poliomyelitis in man. 
The experiments to be described were carried out in the following 
manner.  An active,  fresh poliomyelific virus was  obtained  in  the 
usual manner by inoculating a  monkey intracerebrally with a  sus- 
pension of glycerolated virus.  On the 1st day of complete prostra- 
tion,  the animal was etherized, and the brain and spinal cord were 
l0 Flexner, S., and Amoss, H. L., J. Exp. Med., 1914,  xx, 249. 
u Flexner, S., and Amoss, H. L., J. Exp. Med., 1917,  xxv, 525. 312  ROSENOW~S  ANTIPOLIOMYELITIC  SERUM 
aseptically removed.  With the spinal cord and medulla, a  5 per cent 
suspension in isotonic salt solution was prepared,  shaken, and centri- 
fuged,  and  the  clear  supernatant  fluid  injected  intravenously  into 
Macacus rhesus monkeys.  Twoseparate sets of experiments were per- 
formed.  Control animals and animals treated with Rosenow's serum, 
with  normal  horse  serum,  and  with  convalescent  monkey  serum, 
in  the  same  manner,  were  tested  simultaneously.  The  protocols 
follow.  The  outcome is  as  sharp  and  hence  as  decisive  as  the  ex- 
perimental  results  could make it. 
Experiment/.--Monkey  A, control.  Nov. 13,  1917.  Injected intravenously 
50 cc. of the virus prepared as described.  The animal  remained  well. 
Monkey B, normal horse serum control.  Nov. 12,  1917, 5.10 p.m.  Injected 
intraspinally 2.5 cc. of normal horse serum.  Nov. 13,  11.15 a.m.  Injected in- 
travenously 50 cc. of virus.  12 noon.  Injected intraspinally  2.5 cc. of normal 
horse  serum.  Nov.  14.  Injected intraspinally 2.5  cc. of normal  horse  serum, 
Nov. 15.  Repeated intraspinal  injection of normal horse serttm.  Nov. 16.  Re- 
peated  intraspinal  injection  of normal  horse  serum.  Protects left leg;  ataxic. 
Nov.  17,  a.m.  Left arm,  right deltoid,  and both legs paralyzed; head tremor; 
ptosis  of the left eyelid; almost prostra~.  4.30 p.m.  Died. 
Autopsy.--Macroscopic and microscopic lesions  of poliomyelitis.  No visible 
changes in viscera. 
Monkey C, Rosenow's serum.  Nov. 12, 1917, 4.40 p.m.  Intraspinal injection 
of 3 cc. of Rosenow's antipoliomyelitic  horse serum activated with one-ninth vol- 
ume of fresh guinea  pig serum.  Nov. 13,  10.45 a.m.  Intravenous injection  of 
50 cc. of virus.  10.50  a.m.  Intraspinal injection  of 3 cc. of Rosenow's serum. 
Nov. 14,  I5,  18,  19, and 20.  Injected 3 cc. of Rosenow's serum,  intraspinally. 
The  clinical  course  of the  animal  was  as  follows: Nov.  17.  Slow.  Nov.  19. 
Excited; slow; protects right leg.  Nov. 20.  Drags right leg; climbs awkwardly. 
Nov. 22.  Both legs weak.  Nov. 23.  Legs paralyzed; deltoids weak.  Nov. 24. 
Prostrate (Fig.  1).  Nov. 26.  Moribund; etherized. 
Autopsy.--The spinal cord and brain ~vere edematous and the gray matter was 
congested.  Microscopic  examination  of  the  central  nervous  system  showed 
marked perivascular  infiltration  and some neurophagocytosis  in the gray matter 
of the medulla and cervical enlargement  characteristic  of poliomyelitis.  Perlvas- 
cular infiltration  (Figs.  2 and 3),  congestion,  neurophagocytosls,  and meningeal 
infiltration  in lumbar enlargement.  Focal infiltration  of lymphocytes, cell de- 
generation,  and neurophagocytosis in the posterior root ganglia. 
Monkey D, serum  of recovered  monkeys.  Nov. 12,  1917, 4.55 p.m.  Intra- 
spinal injection  of 3 cc. of mixed serums from several rhesus monkeys which had 
recovered from experimental  poliomyelitis  and  subsequently received subcuta- 
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immune).  Nov. 13, 11  a.m.  Intravenous injection of 50 cc.  of virus  suspen- 
sion followed by intraspinal injection of 3 cc. of immune serum.  Nov.  14,  15, 
18,  19, and 20.  Intraspinal injections of 3 cc. of immune seru~m.  The clinical 
course of this animal was in striking contrast with the preceding.  At no time 
were any symptoms present; the animal continued apparently normal  through- 
out the treatment and is well at the present time (Jan. 1, 1918). 
This  experiment  was  repeated  with precisely  the  same  results. 
The protocols follow.  In  the second experiment,  the normal  horse 
serum control was omitted. 
E~p~r/me~ 2.--Monkey E, control,  Nov. 26, 191.7.  Intravenous injection of 
50 cc. of the virus.  No symptoms appeared, and the animal has remained normal 
up to the present time (Jan. 1, 1918). 
Monkey F, Rosenow's serum.  Nov. 26, I917, 6 p.m.  Intraspinal injection of 
2 cc. of activated Rosenow'santipoliomyelitic h~orse serum.  Nov. 27~ 11.35 a.m. 
Intravenous injection of 50 cc. of virus, followed immediately by the intraspinal 
injection of 2.5  ce.  of Rosenow's serum.  The intraspinal  injections  were  re- 
peated on Nov. 28, 29, Dec. 2, and 3.  In each instance the activated serum was 
injected.  Dec. 3.  The animal developed a marked tremor of the head, ataxia, 
and right facial paralysis; also,  the deltoid muscles  were weak.  Dec, 4.  The 
monkey died in the early morning. 
Autopsy.~Macroseopic lesions  of poliomyelitis  throughout blain  and  cord. 
Microscopic examination of the central nervous system showed marked congestion 
and perivascular infiltration, slight cell degeneration, and neurophagocytosis in 
medulla and'cervical enlargement (Fig. 4) ; slight meningeal  infiltration in lumbar 
enlargement, and focal infiltration of lymphocytes, cell degeneration, and neuro- 
phagocytosis in posterior root ganglia  (Fig. 5). 
Monkey G, immune monkey serum.  Nov. 26, 1917, 5.15 p.m.  2 cc. of pooled 
immune serum injected intraspin~lly.  Nov. 27,  12.25 p.m.  Intravenous injec- 
tion of 50 cc. of the virus, followed by the intraspinal injection of 2.5 cc. of pooled 
immune serum.  The intraspinal injections of the pooled serum were repeated on 
Nov. 28, 29, Dec. 2, and 3.  At no time were any symptoms detected, and the 
animal is normal at this time (Jan. 1, 1918). 
DISCUSSION. 
The  preceding  experiments  accomplish  two  purposes  directly. 
First,  they test the ability of Rosenow's serum, which was prepared 
by injecting  a  horse with  cultures  of the  streptococci derived from 
poliomyelitic  nervous  organs,  to  prevent  a  poliomyelitic  infection 
arising  in  the  monkey  after  an  intravenous  injection  of  the  virus. 
This is readily accomplished by means of the immune serum obtained 314  ROSENOW~S ANTIPOLIOMYELITIC ,SERUM: 
from convalescent and  recovered monkeys.  Second,  they compare 
directly under  these  favorable  therapeutic  conditions  the  Rosenow 
serum with the serum of immune monkeys. 
The results of the experiments are unequivocal.  They show  the 
Rosenow serum to  be devoid of protective power.  Moreover, they 
show that  the Rosengw serum acts in  the manner of normal  horse 
serum in  promoting infection in monkeys from an  intravenous in- 
jection of the virus, in itself incapable of inducing paralysis. 
The immune monkey serum possesses,  under the same conditions 
of administration, perfect protective power, as has been shown pre- 
viously by Ftexner and Amass.  n 
A further conclusion may be drawn from the experiments.  Rosa- 
now states that the horse serum prepared by him contains demonstra- 
ble antibodies for the streptococci employed in its production.  It is 
assumed  that  these  antibodies  are  identical  with  the  antibodies, 
demonstrable by neutralization experiments with the virus, contained 
within human and monkey serum  derived from recovered cases of 
poliomyelitis in man and the monkey.  This supposition is rendered 
untenable by the results of our experiments.  The antibodies induced 
in  the  horse  by  immunization  with  the  streptococci  have  proven 
incapable of neutralizing the virus  of poliomyelitis introduced into 
the blood of monkeys in its passage to the central nervous system-- 
a  neutralization  which  the  immune monkey serum  readily  effects. 
The two classes of antibodies or  immunity principles,  those present 
in the blood derived from recovered cases of poliomyelitis and those 
induced in  the horse by treatment with streptococci,  are  therefore 
to be regarded as distinct. 
There is a  further corollary to  this general deduction.  Once it is 
established  that  the  antibodies  yielded  by  the  streptococci  differ 
essentially from those induced by the virus of poliomyelitis, the con- 
tention that virus and streptococci are identical becomes untenable. 
In other words, the experiments reported in this paper tend also  to 
refute the claim that certain streptococci are the microbic cause of 
epidemic poliomyelitis. 
Rosenow and Nuzum and Willy assert  that  their serums possess 
striking therapeutic activity in man.  Their conclusions are based on 
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myelitis  during  the  past  summer and autumn.  We  have  already 
drawn attention to the difficulties surrounding a  statistical study, of 
limited extent, of  the  questions  here  involved.  Hence we venture 
to place, in this instance, the greater weight on  decisive animal  ex- 
periments, and those reported in this paper clearly show that Rose- 
now's  horse  sertnn  injected  intraspinally  into  monkeys is without 
specific protective power against the virus of poliomyelitis. 
It has, however, been shown by Flexner and Amoss  1~ that normal 
horse serum, when injected intraspinally into monkeys, promotes the 
passage  of  poliomyelitic  immune  bodies  from  the  blood  into  the 
subarachnoid space.  Hence it is possible that under certain circum- 
stances in which those bodies are already present in the blood in man, 
they may be directed into  the subarachnoid space through the in- 
creased permeability of the meninges induced by the horse serum and 
thus  affect  the course of  the infection.  The antibodies have been 
detected on the 3rd  13 and 6th  1. days of illness in man, or, in other 
words, early in the course of the disease. 
This, however, is a purely hypothetical consideration, in support of 
which normal horse serum should prove  as effective as antistrepto- 
coccus sermn.  It is questionable whether this roundabout method 
of directing the circulating immunity bodies to the central nervous 
organs is advisable in practice.  As far as present knowledge, based 
on definitive experiments, is concerned, it may be said that only im- 
mune serum derived from convalescent and recovered cases of polio- 
myelitis in man and-the monkey have been determined to be pro- 
tective against the infectious power of the poliomyelitic virus. 
CONCLUSIONS. 
Two series of experiments are described in which Rosenow's anti- 
poliomyelific serum,  so called, has been compared with the immune 
serum  derived from monkeys which have  convalesced or recovered 
from experimental poliomyelitis. 
The experiments consisted in introducing an active virus of polio- 
12 Flexner, S., and Amoss, H. L., J. Exp. Med., 1917, xxv, 499. 
13 Kling, C. A., and Levaditi, C., ]~tudes sur ]a poliomy~lite  aigu~ ~pid~miquet 
Paris, 1913, p. 114. 316  I~OSENOW'S  ANTIPOLIOMYELITIC  SERU~ 
myelitis into the blood and of injecting the two kinds of serum into 
the cerebrospinal meninges according to the method of Flexner and 
2~0SS. 
Under the conditions of the experiment, the control monkeys (a) 
receiving  the  virus  intravenously  alone  do  not  develop  paralysis, 
while those  (b)  receiving the virus intravenously and normal horse 
serum intraspinally develop paralysis.  Moreover, the monkeys (c) re- 
ceiving  the  virus  intravenously  and  Rosenow's  antipoliomyelitic 
serum intraspinally develop paralysis in the manner of those receiving 
normal horse seruln intraspinally.  The monkeys (d)  which received 
the  virus  intravenously and  the  convalescent  or  immune monkey 
serum intraspinally alone did not develop paralysis. 
The Rosenow serum acts in the manner of normal horse serum;  it 
promotes the passage of the virus of poliomyelitis from the blood into 
the nervous organs, and it does not protect from infection. 
We have found no evidence that Rosenow's serum under the con- 
ditions  of the  tests  is  effective therapeutically in monkeys or pos- 
sesses antibodies of the same nature as those present in the blood of 
monkeys which have recovered from experimental poliomyelitis. 
Since  the antibodies  in  convalescent poliomyelitic serum in  man 
and the monkey are identical, it follows that any antibodies present 
in  the Rosenow horse serum do not conform to  those occurring in 
human convalescent serum. 
EXPLANATION OF PLATES. 
The illustrations were taken from monkeys treated with Rosenow's serum. 
PLATE 8. 
FIG.  l.  Monkey C.  11 days after  the intravenous  injection of virus.  Re- 
ceived seven intraspinal injections of  Rosenow's serum.  Arms, legs, and back 
muscles paralyzed; face muscles active. 
PLATE 9. 
FIG. 2.  Monkey C.  Cervical enlargement showing perivascular mononuclear 
cell infiltration in anterior horn.  X  165. 
FIC. 3.  Monkey C.  Cervical enlargement showing perivascular mononuclear 
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PLATE 10. 
• FIG.  4.  Monkey F.  Cervical  enlargement  showing anterior  horn  with  de- 
generation of ganglion cells and neurophagocytosis.  X  240. 
FIG.  5.  Monkey F.  Posterior root ganglion with ganglion cell degeneration, 
neurophagocytosis, and mononuclear cell infiltration.  X  240. THE JOURNAL OF EXPERIMENTAL MEDICINE VOL. XXVll.  PLATE 8. 
(Amoss and Eberson:  Rosenow's antipoliomyelitic serum.) THE JOURNAL  OF  EXPERIMENTAL  MEDICINE VOL.  XXVII.  PLATE 9. 
Fio.  2. 
Fro. 3. 
(Amoss  and  Eberson:  Rosenow's antiDollomyelitic serum.~ THE JOURNAL OF  EXPERIMENTAL  MEDICINE VOL.  XXVII.  PLATE  10. 
FIG.  4. 
FZG.  5. 
(Amoss  and  Eberson: Rosenow's antipoliomyelitie  serum.) 